Journal
STEM CELLS TRANSLATIONAL MEDICINE
Volume 3, Issue 5, Pages 653-661Publisher
WILEY
DOI: 10.5966/sctm.2013-0184
Keywords
Diabetes mellitus; Regenerative medicine; Stem cells; Translation; Transplantation
Categories
Funding
- Eisenberg Stem Cell Trust
- Marriott Foundation
- Bernard and Edith Waterman Pilot Grant
- Mayo Clinic Center for RegeneratiVe Medicine
Ask authors/readers for more resources
Diabetes engenders the loss of pancreatic beta-cell mass and/or function, resulting in insulin deficiency relative to the metabolic needs of the body. Diabetic care has traditionally relied on pharmacotherapy, exemplified by insulin replacement to target peripheral actions of the hormone. With growing understanding of the pathogenesis of diabetic disease, alternative approaches aiming at repair and restoration of failing beta-cell function are incrdasingly considered as complements to current diabetes therapy regimens. To this end, emphasis is placed on transplantation of exogenous pancreas/islets or artificial islets, enhanced proliferation and maturation of endogenous beta cells, prevention of beta-cell loss, or fortified renewal of beta-like-cell populations from stem cell pools and non-beta-cell sources. In light of emerging clinical experiences with human embryonic stem cells and approval of the first in-human trial with induced pluripotent stem cells, in this study we highlight advances in beta-cell regeneration strategies with a focus on pluripotent stem cell platforms in the context of translational applications.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available